| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2022 | Jan 10, 2022 | Amylyx Pharmaceuticals, Inc. | Director | Buy | 95.0 | +3,947 | 100.00% | ✗ | $75K |
| May 8, 2020 | May 12, 2020 | Apellis Pharmaceuticals, Inc. | Director | Buy | 95.0 | +5,000 | 100.00% | ✗ | $159K |